New Ray Medicine International Holding Ltd.

New Ray Medicine International Holding Ltd.

New Ray Medicine International Holding Ltd.

Overview
Date Founded

2012

Headquarters

B-C, 37th Floor,Dikai International Center,19 Dangui Road,Hangzhou, Zhejiang 311112

Type of Company

Public

Employees (Worldwide)

35

Industries

Pharmaceuticals
Holding Companies

Company Description

New Ray Medicine International Holding Ltd. is an investment company, which engages in the distribution and trading of pharmaceutical products. It operates through the following business segments: Injection Drugs; Capsule and Granule Drugs; Tablet Drugs; Marketing and Promotion Services; and Others. The Injection Drugs segment includes the trading of injection drugs. The Capsule and Granule Drugs segment relates to the selling of capsule and granule drugs. The Tablet Drugs segment comprises tablet drugs. The Marketing and Promotion Services segment focuses in the marketing and promotion of services of drugs. The Others segment trades miscellaneous types of goods and drugs, other than injection drugs, capsule and granule drugs, and tablet drugs. The company was founded on August 9, 2012 and is headquartered in Hangzhou, China.

Executives & Employees

Chief Executive Officer & Executive Director

Executive Director

Executive Director

Secretary & Financial Controller

Board of Directors

Executive Director at New Ray Medicine International Holding Ltd.

Chief Executive Officer & Executive Director at New Ray Medicine International Holding Ltd.

Independent Non-Executive Director at New Ray Medicine International Holding Ltd.

Independent Non-Executive Director at New Ray Medicine International Holding Ltd.

Independent Non-Executive Director at New Ray Medicine International Holding Ltd.

Executive Director at New Ray Medicine International Holding Ltd.

Paths to New Ray Medicine International Holding Ltd.
Potential Connections via
Relationship Science
You
New Ray Medicine International Holding Ltd.
Recent Transactions
Details Hidden

Major Bright Holdings Ltd., New Ray Medicine International Holding Ltd. purchase WinHealth International Co Ltd.

Details Hidden

New Ray Medicine International Holding Ltd., Major Bright Holdings Ltd. purchase C&C International Healthcare Group Ltd.

Details Hidden

New Ray Medicine International Holding Ltd. issued HKD Ordinary Shares

Transaction Advisors
Underwriter

Advised onNew Ray Medicine International Holding Ltd. issued HKD Ordinary Shares

Legal Advisor

Advised onNew Ray Medicine International Holding Ltd. issued HKD Ordinary Shares

Auditor

Advised onNew Ray Medicine International Holding Ltd. issued HKD Ordinary Shares

Key Stats and Financials As of 2019
Market Capitalization
$711M
Total Enterprise Value
$541M
Earnings Per Share
$-0.03
Revenue
$119M
Net Profit
$-44.1M
EBITDA
$-21.3M
EBITDAMargin
-17.96%
Total Debt
$2.18M
Total Equity
$654M
Three Year Compounded Annual Growth Rate Of Revenue
-18.43%
Five Year Compounded Annual Growth Rate Of Revenue
-8.6%
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by New Ray Medicine International Holding Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of New Ray Medicine International Holding Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and New Ray Medicine International Holding Ltd..